Oragenics Inc. Stock
Your prediction
Pros and Cons of Oragenics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Oragenics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Oragenics Inc. | - | - | - | - | - | - | - |
| Solasia Pharma KK | 4.480% | 3.053% | 16.379% | -43.750% | 1.504% | -48.473% | -86.224% |
| Larimar Therapeutics Inc. | -1.130% | 1.807% | 19.858% | 20.714% | 1.807% | -7.143% | -60.925% |
| Northwest Biotherapeutics Inc. | 0.000% | -12.000% | -26.667% | -43.590% | -35.922% | -72.840% | -86.931% |
Comments
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat